Medreich Limited Bisacodyl Export Data — India (DGFT 2022–2026)

Name: Medreich Limited Bisacodyl Export Records India — #5 Exporter, 21 Shipments, $399.9K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-06-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Bisacodyl

India Pharmaceutical Trade Intelligence

$8.6M240 Suppliers108 CountriesHS 30049099

ExportsIndia → UNITED KINGDOM48.4%India → UNITED STATES9.9%

ImportsGERMANY → India$362 JAPAN → India$169

Medreich Limited — Bisacodyl Exporter #5 | $399.9K Trade Value | TransData Nexus | TransData Nexus

Medreich Limited — Bisacodyl Exporter Profile

Indian Pharmaceutical Exporter · #5 for Bisacodyl · $399.9K export value · DGFT Verified

Medreich Limited is the #5 Indian exporter of Bisacodyl with $399.9K in export value and 21 verified shipments. Medreich Limited holds a 4.6% market share in Bisacodyl exports across 5 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.

Medreich Limited — Bisacodyl Export Profile: Buyers & Destinations

Medreich Limited Bisacodyl export treemap — buyers and destination countries | TransData Nexus

Where Does Medreich Limited Export Bisacodyl?

Country	Value	Shipments	Share
CZECH REPUBLIC	$154.0K	7	38.5%
FRANCE	$148.5K	5	37.1%
NEW ZEALAND	$67.7K	6	16.9%
AUSTRALIA	$25.2K	2	6.3%
NIGERIA

Who Are the Top Buyers of Bisacodyl from Medreich Limited?

Buyer	Country	Value	Orders
SUBSTIPHARM	FRANCE	$148.5K	5
MEDIS INTERNATIONAL AS	CZECH REPUBLIC	$70.7K	3
MEDIS INTERNATIONAL A.S.	CZECH REPUBLIC	$62.3K	3
VIATRIS NEW ZEALAND	NEW ZEALAND	$55.4K	5
MEDREICH AUSTRALIA PTY LTD	AUSTRALIA	$25.2K	2
MEDIS INTERNATIONAL A S	CZECH REPUBLIC	$21.0K	1
MYLAN NEW ZEALAND LTD	NEW ZEALAND	$12.4K	1
AGUAWKA VENTURES LTD	NIGERIA	$4.4K	1

Medreich Limited supplies Bisacodyl to 8 buyers globally. The largest buyer is SUBSTIPHARM (FRANCE), followed by MEDIS INTERNATIONAL AS (CZECH REPUBLIC) and MEDIS INTERNATIONAL A.S. (CZECH REPUBLIC). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Bisacodyl Formulations Does Medreich Limited Export?

Product Description / Formulation	Value	Shipments
BISACODYL GASTRO RESISTANT TABLETS 5MG,3	$62.3K	3
BISACODYL GASTRO RESISTANT TABLETS 5MG,30000S234.972	$35.2K	1
BISACODYL 5MG TABLETS( Bisacodyl ViatrisConseil 5MG) (3X10'S) (46860 packs)	$30.9K	1
BISACODYL 5MG TABLETS( Bisacodyl ViatrisConseil 5MG) (3X10'S) (45636 packs)	$30.1K	1
BISACODYL 5MG TABLETS (BISACODYL VIATRISCONSEIL 5MG) 3X10'S(QTY 45900)	$30.0K	1
BISACODYL 5MG TABLETS (BISACODYL VIATRISCONSEIL 5MG) 3X10'S(QTY 45564)	$29.8K	1
BISACODYL GASTRO RESISTANT TABLETS 5MG 30000SQTY-189.140	$28.4K	1
BISACODYL 5MG TABLETS( Bisacodyl ViatrisConseil 5MG) 3X10S(46380 PACKS)	$27.7K	1
BISACODYL TABLETS 5MG (BISACODYL VIATRIS	$25.8K	2
BISACODYL GASTRO RESISTANT TABLETS 5MG 30000S 141 038 QTY	$21.0K	1

Medreich Limited exports 18 distinct Bisacodyl formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BISACODYL GASTRO RESISTANT TABLETS 5MG,3 with 3 shipments worth $62.3K.

How Does Medreich Limited Compare to Nearest Bisacodyl Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	BLISS GVS PHARMA LIMITED	$712.9K	26	3	$27.4K
4	DR REDDYS LABORATORIES LIMITED	$458.7K	12	1	$38.2K
5	MEDREICH LIMITED ★	$399.9K	21	5	$19.0K
6	DR.REDDY'S LABORATORIES LIMITED	$291.9K	19	1	$15.4K
7	DR REDDY S LABORATORIES LIMITED	$282.8K	10	1	$28.3K

Medreich Limited ranks #5 among 240 Indian Bisacodyl exporters. Average shipment value of $19.0K compared to the market average of $26.5K. The closest competitors by value are BLISS GVS PHARMA LIMITED and DR REDDYS LABORATORIES LIMITED.

Which Indian Ports Ship Bisacodyl Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	168	13.0%
NHAVA SHEVA SEA (INNSA1)	159	12.3%
SAHAR AIR	152	11.7%
JNPT/ NHAVA SHEVA SEA	74	5.7%
HYDERABAD ICD	60	4.6%
JNPT	58	4.5%
Bombay Air	42	3.2%
AHEMDABAD ICD	32	2.5%

Geopolitical & Trade Policy Impact on Medreich Limited's Bisacodyl Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)

Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)

The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)

Medreich Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)

For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Bisacodyl shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Medreich Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 21 individual customs records matching Medreich Limited exporting Bisacodyl, covering 18 formulations to 5 countries via 8 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 108+ countries, 415+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Bisacodyl

Bisacodyl

Medreich Limited — Bisacodyl Exporter Profile

Medreich Limited — Bisacodyl Export Profile: Buyers & Destinations

Where Does Medreich Limited Export Bisacodyl?

Who Are the Top Buyers of Bisacodyl from Medreich Limited?

What Is India's Total Bisacodyl Export Value and How Much Does Medreich Limited Contribute?

What Is the Average Shipment Value for Medreich Limited's Bisacodyl Exports?

How Does Medreich Limited Compare to Other Indian Bisacodyl Exporters?

What Bisacodyl Formulations Does Medreich Limited Export?

How Does Medreich Limited Compare to Nearest Bisacodyl Exporters?

Which Indian Ports Ship Bisacodyl Exports?

Geopolitical & Trade Policy Impact on Medreich Limited's Bisacodyl Exports

Medreich Limited — Regulatory Compliance & Quality Standards

About Medreich Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Bisacodyl Export Data from Medreich Limited

Bisacodyl Stats

Company Overview

Top Products by Medreich Limited

Related Analysis

Need Detailed Export Data?

Data Source